Cargando…

Efficacy and safety of Tianmabianchunzhigan in mild to moderate vascular dementia: Protocol of a randomized controlled IIa trial

BACKGROUND: Vascular dementia (VaD) is the 2nd most common subtype of dementia after Alzheimer disease. Currently, there are no medications approved for treating patients with VaD. Tianmabianchunzhigan (TMBCZG) tablet is an active ingredient extracted from Gastrodia that has been reported to improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Jinzhou, Shi, Jing, Wei, Mingqing, Li, Ting, Ni, Jingnian, Zhang, Xuekai, Zhang, Meng, Li, Yang, Wang, Yongyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319825/ https://www.ncbi.nlm.nih.gov/pubmed/30572524 http://dx.doi.org/10.1097/MD.0000000000013760

Ejemplares similares

The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial
por: Tian, Jinzhou, et al.
Publicado: (2016)

Herbal formula GAPT prevents beta amyloid deposition induced Ca(2+)/Calmodulin-dependent protein kinase II and Ca(2+)/Calmodulin-dependent protein phosphatase 2B imbalance in APPV717I mice
por: Shi, Jing, et al.
Publicado: (2016)

Retraction Note: Herbal formula GAPT prevents beta amyloid deposition induced Ca(2+)/Calmodulin-dependent protein kinase II and Ca(2+)/Calmodulin-dependent protein phosphatase 2B imbalance in APPV717I mice
por: Shi, Jing, et al.
Publicado: (2021)

Adding Chinese herbal medicine to conventional therapy brings cognitive benefits to patients with Alzheimer’s disease: a retrospective analysis
por: Shi, Jing, et al.
Publicado: (2017)

The Chinese version of story recall: a useful screening tool for mild cognitive impairment and Alzheimer’s disease in the elderly
por: Shi, Jing, et al.
Publicado: (2014)

Efficacy and safety of SQJZ herbal mixtures on nonmotor symptoms in Parkinson disease patients: Protocol for a randomized, double-blind, placebo-controlled trial
por: Shi, Jing, et al.
Publicado: (2017)

The influence of GAPT extraction on synapse loss of APPswe/PS1dE9 transgenic mice via adjusting Bcl-2/Bax balance
por: Shi, Jing, et al.
Publicado: (2018)

A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer’s disease in a Chinese population
por: Wei, Mingqing, et al.
Publicado: (2019)

The utility of the Hopkins Verbal Learning Test (Chinese version) for screening dementia and mild cognitive impairment in a Chinese population
por: Shi, Jing, et al.
Publicado: (2012)

Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson’s disease: a Chinese population-based study
por: Li, Ting, et al.
Publicado: (2019)

Peripheral Blood and Cerebrospinal Fluid Levels of YKL-40 in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Zhang, Yuchen, et al.
Publicado: (2023)

The Pattern Element Scale: A Brief Tool of Traditional Medical Subtyping for Dementia
por: Shi, Jing, et al.
Publicado: (2013)

Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer’s disease dementia in Chinese individuals
por: Sun, Qingling, et al.
Publicado: (2022)

A combination extract of ginseng, epimedium, polygala, and tuber curcumae increases synaptophysin expression in APPV717I transgenic mice
por: Shi, Jing, et al.
Publicado: (2012)

Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial
por: Shi, Jing, et al.
Publicado: (2020)

Herbal therapy: a new pathway for the treatment of Alzheimer's disease
por: Tian, Jinzhou, et al.
Publicado: (2010)

Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review
por: Teng, Yuou, et al.
Publicado: (2022)

Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial
por: Tian, Jinzhou, et al.
Publicado: (2017)

Plasma repressor element 1-silencing transcription factor levels are decreased in patients with Alzheimer's disease
por: Wei, Mingqing, et al.
Publicado: (2022)

Effect of hearing aids on cognitive functions in middle-aged and older adults with hearing loss: A systematic review and meta-analysis
por: Yang, Zhizhong, et al.
Publicado: (2022)

Chinese herbal medicine Qinggongshoutao for the treatment of amnestic mild cognitive impairment: A 52-week randomized controlled trial
por: Tian, Jinzhou, et al.
Publicado: (2019)

Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia
por: Hannestad, Jonas, et al.
Publicado: (2020)

Systematic review: clinical characteristics of anti-N-methyl-D-aspartate receptor encephalitis
por: Zhao, Xi, et al.
Publicado: (2023)

Acupuncture Can Regulate the Distribution of Lymphocyte Subsets and the Levels of Inflammatory Cytokines in Patients With Mild to Moderate Vascular Dementia
por: Zhi, Hui, et al.
Publicado: (2021)

Cognitive training and cognitive rehabilitation for persons with mild to moderate dementia of the Alzheimer's or vascular type: a review
por: Bahar-Fuchs, Alex, et al.
Publicado: (2013)

Vascular Risk as a Predictor of Cognitive Decline in a Cohort of Elderly Patients with Mild to Moderate Dementia
por: Curiati, Pedro K., et al.
Publicado: (2014)

Feasibility and Safety of Perilla Seed Oil as an Additional Antioxidative Therapy in Patients with Mild to Moderate Dementia
por: Kamalashiran, Chuntida, et al.
Publicado: (2018)

Benefits and Safety of Astaxanthin in the Treatment of Mild-To-Moderate Dry Eye Disease
por: Tian, Lei, et al.
Publicado: (2022)

Cognitive Stimulation Therapy as an Adjunctive Treatment for Mild to Moderate Dementia
por: Kumar, S. Sandeep, et al.
Publicado: (2023)

Goal Setting for Cognitive Rehabilitation in Mild to Moderate Parkinson's Disease Dementia and Dementia with Lewy Bodies
por: Watermeyer, Tamlyn J., et al.
Publicado: (2016)

Unmet Needs and Behavioral Expressions: The Perspective of Individuals with Mild to Moderate Dementia
por: Minyo, Morgan, et al.
Publicado: (2020)

Moderators of Dual Task Gait Effects in Mild Cognitive Impairment and Dementia
por: Ofori, Edward, et al.
Publicado: (2021)

Progression to vascular dementia of patients with mild cognitive impairment: relevance of mild parkinsonian signs
por: Mauri, Marco, et al.
Publicado: (2008)

Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial
por: Sasson, Jennifer, et al.
Publicado: (2022)

Real-world Evaluation of Tolerability, Safety and Efficacy of Rivastigmine Oral Solution in Patients with Mild to Moderate Alzheimer’s Disease Dementia
por: Hsieh, Sun-Wung, et al.
Publicado: (2021)

Physical Performance and Quality of Life of Nursing-Home Residents with Mild and Moderate Dementia
por: Telenius, Elisabeth Wiken, et al.
Publicado: (2013)

Persistence and Prognostic Implications of Orthostatic Hypotension in Older Individuals with Mild-to-Moderate Dementia
por: Soennesyn, Hogne, et al.
Publicado: (2014)

Resilience in caregivers of people with mild-to-moderate dementia: findings from the IDEAL cohort
por: Martyr, Anthony, et al.
Publicado: (2023)

Expression of one important chaperone protein, heat shock protein 27, in neurodegenerative diseases
por: Zhang, Xuekai, et al.
Publicado: (2014)

Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND)
por: Stephan, Blossom CM, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_gkaics2h7lmshlvhed3v7in52e